Mutual paracrine effects of colorectal tumour cells and stromal cells: Modulation of tumour and stromal cell differentiation and extracellular matrix component production in culture

International Journal of Experimental Pathology

Volumn 86, Issue 4, 2005, Pages 219-229

  Mukaratirwa, Sydney ^a,b   Koninkx, Jos F ^a   Gruys, Erik ^a   Nederbragt, Hubertus ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Colon carcinoma cells; Cytokines; Extracellular matrix; Myofibroblasts; Phenotypic transdifferentiation; Stromal cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CHONDROITIN 6 SULFATE; CHONDROITIN SULFATE; COLLAGEN GEL; CYTOKINE; DESMIN; PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; VERSICAN; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL INTERACTION; COCULTURE; COLORECTAL TUMOR; DOG; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MODULATION; MYOFIBROBLAST; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR CELL;

ACTINS; ANIMALS; CACO-2 CELLS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CHONDROITIN SULFATES; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; DOGS; EXTRACELLULAR MATRIX; FIBROBLASTS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MUSCLE, SMOOTH; NEOPLASM PROTEINS; PHENOTYPE; PROTEOCHONDROITIN SULFATES; STROMAL CELLS; TENASCIN; VERSICANS;

EID: 23044488163     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2005.00425.x     Document Type: Article

References (40)

1. Atula S., Grenman R., Syrjanen S. (1997) Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. Exp. Cell. Res. 235, 180-187.
2. Basset P., Bellocq J.P., Wolf C. et al. (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.) 348, 699-704.
3. Caterson B., Mahmoodian F., Sorrell J.M. et al. (1990) Modulation of native chondroitin sulphate structure in tissue development and in disease. J. Cell Sci. 97, 411-417.
4. Chiquet-Ehrismann R., Kalla P., Pearson C.A. (1989) Participation of tenascin and transforming growth factor-beta in reciprocal epithelial- mesenchymal interactions of MCF7 cells and fibroblasts. Cancer Res. 49, 4322-4325.
5. Desmouliére A., Geino Z. A., Gabbiani F., Gabbiani G. (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122, 103-111.
6. Donjacour A.A. & Cunha G.R. (1991) Stromal regulation of epithelial function. Cancer Treat. Res. 53, 335-364.
7. Gabbiani G. (1981) The myofibroblast: a key cell for wound healing and fibrocontractive diseases. Prog. Clin. Biol. Res. 54, 183-194.
8. Gabbiani G., Hirschel B.J., Ryan G.B., Statkov P.R., Majno G. (1972) Granulation tissue as a contractile organ. A study of structure and function. J. Exp. Med. 135, 719-734.
9. Gabbiani G., Ryan G.B., Majno G. (1971) Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27, 549-550.
10. Halttunen T., Marttinen A., Rantala I., Kainulainen H., Maki M. (1996) Fibroblasts and transforming growth factor beta induce organization and differentiation of T84 human epithelial cells. Gastroenterology 111, 1252-1262.
11. Hanamura N., Yoshida T., Matsumoto E., Kawarada Y., Sakakura T. (1997) Expression of fibronection and tenascin-C mRNA by myofibroblast, vascular cells and epithelial cells in human colon adenomas and carcinomas. Int. J. Cancer 73, 10-15.
12. Hauptmann S., Zardi L., Siri A. et al. (1995) Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab. Invest. 73, 172-182.
13. Ishihara A., Yoshida T., Tamaki H., Sakakura T. (1995) Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin. Cancer Res. 1, 1035-1041.
14. Karvinen S., Kosma V.M., Tammi M.I., Tammi R. (2003) Hyaluronan, CD44 and versican in epidermal keratinocyte tumours. Br. J. Dermatol. 148, 86-94.
15. Kinner B., Zaleskas J.M., Spector M. (2002) Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp. Cell. Res. 278, 72-83.
16. Koukoulis G.K., Gould V.E., Bhattacharyya A., Gould J.E., Howeedy A.A., Virtanen I. (1991) Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum. Pathol. 22, 636-642.
17. Lesuffleur T., Violette S., Vasile-Pandrea I. et al. (1998) Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype. Int. J. Cancer 76, 383-392.
18. Mukaratirwa S., de Witte E., van Ederen A.M., Nederbragt H. (2003) Tenascin expression in relation to stromal tumour cells in canine gastrointestinal epithelial tumours. J. Comp. Pathol. 129, 137-146.
19. Nakamura K., Kurosaka D., Yoshino M., Oshima T., Kurosaka H. (2002) Injured corneal epithelial cells promote myodifferentiation of corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 43, 2603-2608.
20. Nakamura T., Matsumoto K., Kiritoshi A., Tano Y., Nakamura T. (1997) Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57, 3305-3313.
21. Olumi A.F., Dazin P., Tlsty T.D. (1998) A novel coculture technique demonstrates that normal human prostatic fibroblasts contribute to tumor formation of LNCaP cells by retarding cell death. Cancer Res. 58, 4525-4530.
22. Orend G. & Chiquet-Ehrismann R. (2000) Adhesion modulation by antiadhesive molecules of the extracellular matrix. Exp. Cell. Res. 261, 104-110.
23. Orimo A., Tomioka Y., Shimizu Y. et al. (2001) Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin. Cancer Res. 7, 3097-3105.
24. Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.I., West A.B. (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C9.
25. Ricciardelli C., Brooks J.H., Suwiwat S. et al. (2002) Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin. Cancer Res. 8, 1054-1060.
26. Ricciardelli C., Mayne K., Sykes P.J. et al. (1998) Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin. Cancer Res. 4, 963-971.
27. Ricciardelli C., Mayne K., Sykes P.J. et al. (1997) Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. Clin. Cancer Res. 3, 983-992.
28. van Roozendaal C.E., van Ooijen B., Klijn J.G.M. et al. (1992) Stromal influences on breast cancer cell growth. Br. J. Cancer 65, 77-81.
29. Sappino A.P., Dietrich P.Y., Skalli O., Widgren S., Gabbiani G. (1989) Colonic pericryptal fibroblasts. Differentiation pattern in embryogenesis and phenotypic modulation in epithelial proliferative lesions. Virchows Arch. A Pathol. Anat. Histopathol. 415, 551-557.
30. Sappino A.P., Skalli O., Jackson B., Schurch W., Gabbiani G. (1988) Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 41, 707-712.
31. Schonherr E., Jarvelainen H.T., Sandell L.J., Wight T.N. (1991) Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 266, 17640-17647.
32. Schurch W., Seemayer T.A., Lagace R. (1981) Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light and electron microscopic study. Virchows Arch. A Pathol. Anat. Histol. 391, 125-139.
33. Singer C.F., Rasmussen A., Lippman M.E., Cullen K.J. (1997) Coexpression of stromelysin-3 and insulin-like growth factor II in tumors of ectodermal, mesodermal, and endodermal origin: indicator of a fetal cell phenotype. J. Clin. Endocrinol. Metab. 82, 1917-1922.
34. Touab M., Villena J., Barranco C., Arumi-Uria M., Bassols A. (2002) Versican is differentially expressed in human melanoma and may play a role in tumor development. Am. J. Pathol. 160, 549-557.
35. Tuxhorn J.A., Ayala G.E., Smith M.J., Smith V.C., Dang T.D., Rowley D.R. (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin. Cancer Res. 8, 2912-2923.
36. Valenti M.T., Azzarello G., Balducci E. et al. (2001) Conditioned medium from MCF-7 cell line induces myofibroblast differentiation, decreased cell proliferation, and increased apoptosis in cultured normal fibroblasts but not in fibroblasts from malignant breast tissue. Histochem. J. 33, 499-509.
37. Vollmer G., Tan M.I., Wunsche W., Frank K. (1997) Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-beta. Biochem. Cell Biol. 75, 759-679.
38. Wight T.N. (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell. Biol. 14, 617-623.
39. Wilson K.E., Bartlett J.M., Miller E.P. et al. (1999) Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines. Br. J. Cancer 80, 685-692.
40. Zidar N., Gale N., Kambic V., Fischinger J. (2002) Proliferation of myofibroblasts in the stroma of epithelial hyperplastic lesions and squamous carcinoma of the larynx. Oncology 62, 381-385.